Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

. Rationale and Design of DUAL Study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. Contemporary Clinical Trials Communications 2017; 8:33-38

Date

04/25/2018

Author List

D’Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobson K, Pasquini M, Weihrauch D, Hari P

Author

Anita D'Souza MD Associate Professor in the Medicine department at Medical College of Wisconsin
jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a